12.66
Precedente Chiudi:
$12.14
Aprire:
$12.25
Volume 24 ore:
64,437
Relative Volume:
0.05
Capitalizzazione di mercato:
$127.96M
Reddito:
$88.50M
Utile/perdita netta:
$-35.27M
Rapporto P/E:
-3.8417
EPS:
-3.2954
Flusso di cassa netto:
$-23.70M
1 W Prestazione:
-11.16%
1M Prestazione:
-29.19%
6M Prestazione:
+70.62%
1 anno Prestazione:
+10.66%
Biodesix Inc Stock (BDSX) Company Profile
Nome
Biodesix Inc
Settore
Industria
Telefono
303-417-0500
Indirizzo
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
BDSX
Biodesix Inc
|
12.66 | 122.70M | 88.50M | -35.27M | -23.70M | -3.2954 |
|
TMO
Thermo Fisher Scientific Inc
|
531.67 | 195.93B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
198.14 | 140.56B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
580.76 | 46.39B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
119.77 | 34.02B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
326.20 | 32.49B | 3.17B | 642.63M | 516.49M | 10.77 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-27 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-05-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-07-26 | Iniziato | Craig Hallum | Buy |
| 2024-05-13 | Iniziato | TD Cowen | Buy |
| 2024-05-03 | Iniziato | Lake Street | Buy |
| 2021-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Iniziato | BTIG Research | Buy |
| 2020-11-23 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-23 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-23 | Iniziato | William Blair | Outperform |
Mostra tutto
Biodesix Inc Borsa (BDSX) Ultime notizie
Aberdeen Group plc Takes $1.78 Million Position in Biodesix, Inc. $BDSX - MarketBeat
BDSX Stock Price, Quote & Chart | BIODESIX INC (NASDAQ:BDSX) - ChartMill
Biodesix (NASDAQ: BDSX) outlines 2026 virtual meeting, board and pay votes - Stock Titan
Employees put Biodesix on USA TODAY's Top Workplaces list for a third year - Stock Titan
Rate Hike: Can Biodesix Inc expand into new marketsQuarterly Portfolio Report & Accurate Buy Signal Notifications - baoquankhu1.vn
Biodesix, Inc. (BDSX) stock price, news, quote and history - Yahoo Finance UK
Biodesix Unveils Novel Diagnostic Test at AACR 2026 - National Today
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development - The Manila Times
Biodesix to Showcase Advances in Diagnostic Solutions at AACR Annual Meeting 2026 - Quiver Quantitative
Cancer test developer Biodesix brings 7 studies to AACR meeting - Stock Titan
Is Aura Biosciences (AURA) Stock Outpacing Its Medical Peers This Year? - qz.com
Energy Moves: Can Biodesix Inc expand into new markets2026 Big Picture & Precise Buy Zone Identification - baoquankhu1.vn
BDSX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Biodesix (BDSX) chair adds 1,361 shares through RSU exercise - Stock Titan
Allworth Financial LP Reduces Holdings in Biodesix, Inc. $BDSX - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Wall Street analysts see an 86.45% upside in Biodesix (BDSX): Can the stock really move this high? - MSN
AI Stocks: Can Biodesix Inc expand into new marketsMarket Growth Review & Technical Entry and Exit Tips - baoquankhu1.vn
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Down 19.4% in March - MarketBeat
Weekly Earnings: What is the dividend yield of Biodesix IncQuarterly Portfolio Review & Daily Growth Stock Tips - baoquankhu1.vn
$Biodesix (BDSX.US)$ I am out - moomoo.com
Is Biodesix (BDSX) stock outpacing its medical peers this year? - MSN
If You Invested $1,000 in BIODESIX INC (BDSX) - Stock Titan
Biodesix publishes lung nodule biomarker validation study By Investing.com - Investing.com Australia
Biodesix, Inc.Common Stock (NQ: BDSX - The Chronicle-Journal
Biodesix publishes lung nodule biomarker validation study on 1,100 patients - Investing.com
Biodesix publishes lung nodule biomarker validation study - Investing.com
Biodesix Announces the Largest Lung Nodule Biomarker Clinical Validation Study Ever Published Supporting Earlier Lung Cancer Diagnosis - The Manila Times
Biodesix Publishes Largest Lung Nodule Biomarker Study, Validating Nodify CDT® Test for Lung Cancer Risk Assessment - Quiver Quantitative
Study of 1,100 patients backs blood test for earlier lung cancer diagnosis - Stock Titan
Is Biodesix (BDSX) Shares Performing Better Than Other Medical Stocks This Year? - Bitget
Wall Street Analysts See an 86.45% Upside in Biodesix (BDSX): Can the Stock Really Move This High? - Yahoo Finance
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Treasury Yields: Can Biodesix Inc navigate macro headwinds2026 Pullbacks & Comprehensive Market Scan Insights - baoquankhu1.vn
Biodesix, Inc. (BDSX) reports Q4 loss, beats revenue estimates - MSN
Wall Street analysts think Biodesix (BDSX) could surge 111.62%: Read this before placing a bet - MSN
Decliners Report: Is Biodesix Inc benefiting from innovation trends2026 Pullbacks & Verified Momentum Stock Alerts - baoquankhu1.vn
Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript - MSN
Cannell & Spears LLC Sells 195,326 Shares of Biodesix, Inc. $BDSX - MarketBeat
Biodesix Details Lung Test Momentum, 81% Gross Margin and Growth Plan at Barclays Conference - MarketBeat
Recap Report: What is the dividend yield of Biodesix IncNew Guidance & Accurate Trade Setup Notifications - baoquankhu1.vn
BDSX SEC FilingsBIODESIX INC 10-K, 10-Q, 8-K Forms - Stock Titan
Biodesix Receives 'Moderate Buy' Rating from Analysts - National Today
Biodesix at Barclays Conference: Strategic Growth in Lung Cancer Diagnostics - Investing.com Canada
Biodesix Earnings Call Signals Growth With Caveats - TipRanks
Setup Watch: Is Biodesix Inc in a consolidation phase2026 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
Biodesix, Inc. (NASDAQ:BDSX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Biodesix Details Lung Nodule Growth Plan, Primary Care Push at TD Cowen Healthcare Conference - MarketBeat
Biodesix Inc Azioni (BDSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):